Dr. Steven Fine MD, PhD

Physician, UNIVERSITY OF ROCHESTER MEDICAL CENTER

What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Member of the Healthcare Council

Request a consultation with Steven Fine

Council Member Biography

Steven Fine, MD, PhD is HIV and Infectious Disease Specialist and Assistant Professor in the Infectious Disease Unit at the University of Rochester Medical Center, and Staff Physician at Anthony Jordan Health Center. His clinical expertise is in all aspects of HIV/AIDS care. Dr. Fine has published research in the area of HIV dementia and he is participating in several clinical trials of new treatments for HIV/AIDS diseases. His PhD is in molecular immunology and T cell development. (This is me - Update Profile)


Employment History

2006 - Unspecified
Physician, UNIVERSITY OF ROCHESTER MEDICAL CENTER

GLG NewsSM Analyses by Steven Fine

Opinions and analyses expressed in G+ Insights are solely those of the author. See the Terms of Use for details.


GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Simple potent and safe. This HIV combination will be hard to beat.

August 4, 2006

New AIDS Pill Simplifies Treatment | www.therapeuticsdaily.com

A three drug "cocktail" for treating HIV all in one pill once a day.
The individual components used together but as individual pills have already proven to be among the most potent and safest regimens for patients first starting HIV treatment.
Trials of this combination have not suggested any increase in resistance compared with other combinations.

Request a consultation with Steven Fine

GLG Study Groups with Steven Fine(?)

Study Group Name No. Members
Infectious Diseases Physicians (US) 866
HIV Specialists (US) 353
Physicians who Treat HCV (US) 196
Fuzeon Prescribers for HIV (US) 40
Maraviroc Experts 38

View All Study Groups with Steven Fine

GLG Live Meetings with Steven Fine(?)

Recent Seminars

February 23, 2007 | New York

GLGi: Emerging Therapies for HIV Grand Rounds